NCT03534258

Brief Summary

This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and performance information of the Ceribell EEG system compared to conventional EEG system. The study will recruit physicians (Faculty physicians and Trainees) at up to five institutions and examine the impact of rapid response EEG when providing care to patients in whom EEG recording has been ordered for clinical reasons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

April 30, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

May 23, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

August 20, 2019

Status Verified

August 1, 2019

Enrollment Period

1 year

First QC Date

April 19, 2018

Last Update Submit

August 16, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in physicians' diagnosis decision

    Physician will record their diagnostic assessment of seizure in Yes or No.

    through study completion, an average of 1 year

  • Change in physicians' diagnosis confidence

    Physician will rate their diagnosis confidence with a score between 1 to 5

    through study completion, an average of 1 year

  • Change in physicians' treatment decision

    Physician will record their treatment decision in Yes or No.

    through study completion, an average of 1 year

  • Change in physicians' treatment confidence

    Physician will rate their treatment confidence with a score between 1 to 5

    through study completion, an average of 1 year

Secondary Outcomes (4)

  • Time from order to EEG arrival

    through study completion, an average of 1 year

  • Set up time

    through study completion, an average of 1 year

  • Ease of use

    through study completion, an average of 1 year

  • Signal Quality of EEG

    through study completion, an average of 1 year

Interventions

This trial will qualitatively examine how information from rapid response and conventional EEG data changes physicians' diagnostic suspicion or their treatment decisions and confidence levels. In addition, the results will examine the mean time to EEG lead placement, and ease of use.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will involve two groups of subjects: 1. Physicians (faculty and trainees), who will be asked to fill out a nonsensitive questionnaire. These are members of Epilepsy and Neuro-ICU team (attendings, fellows, or residents) who are actively involved in the care of patients and know the patient's history of present illness. 2. Patients undergoing clinically ordered EEGs.

You may qualify if:

  • Patients undergoing clinically ordered EEGs.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University of California Los Angeles

Los Angeles, California, 90024, United States

Location

Rush University Medical Center Pob

Chicago, Illinois, 60612, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Wake Forest Baptist Health

Winston-Salem, North Carolina, 27157, United States

Location

University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

Location

Related Publications (1)

  • Vespa PM, Olson DM, John S, Hobbs KS, Gururangan K, Nie K, Desai MJ, Markert M, Parvizi J, Bleck TP, Hirsch LJ, Westover MB. Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study. Crit Care Med. 2020 Sep;48(9):1249-1257. doi: 10.1097/CCM.0000000000004428.

MeSH Terms

Conditions

Status EpilepticusSeizures

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2018

First Posted

May 23, 2018

Study Start

April 30, 2018

Primary Completion

April 30, 2019

Study Completion

July 31, 2019

Last Updated

August 20, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations